Drug intelligence / Profile preview

hyaluronic acid + platelet rich plasma

Development stage
Unknown
Lead developer
University of Karachi
Modality
Cell Therapies
Administration
Intraarticular
01

Overview

This combination therapy consists of **Hyaluronic Acid (HA)** and **Platelet-Rich Plasma (PRP)**, which is being evaluated for the treatment of knee osteoarthritis. Hyaluronic acid acts as a viscosupplement, providing mechanical lubrication and shock absorption within the joint to compensate for the loss of synovial fluid quality. Platelet-Rich Plasma is an autologous blood product containing a high concentration of platelets that, upon activation, release various growth factors (such as TGF-β, PDGF, and VEGF) and cytokines. These factors promote tissue repair, stimulate chondrocyte proliferation, and modulate the inflammatory environment of the joint. The combination is hypothesized to have a synergistic effect, where HA improves the joint's physical environment while PRP stimulates biological regenerative processes. A specific study by the **University of Karachi** (NCT04133103) has investigated this combination in patients with Grade II-III knee osteoarthritis.

Other names
HA + PRPHyaluronic Acid and Platelet rich plasma

Beyond the preview

Go deeper on hyaluronic acid + platelet rich plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + platelet rich plasma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call